Drug intelligence / Profile preview

Simex

Development stage: Unknown
Lead developer: Grievers Remedies
Administration: Oral

Overview

**Simex** is an orally administered herbal cough syrup marketed by Grievers Remedies in India for cough. Public product-listing information identifies it as a herbal cough syrup, but does not disclose its botanical ingredients, standardized extract composition, pharmacologic targets, or specific mechanism of action. ([indiamart.com](https://www.indiamart.com/grievers-remidies/products-and-services.html))

Brand names: Simex

Beyond the preview

Go deeper on Simex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Simex.

Explore the full profile